Major Envoy Medical Investor Glen Taylor Discusses How Apple’s AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company
Envoy Medical, Inc. (Nasdaq: COCH), a hearing health company focused on fully implanted hearing systems, highlights an interview with key investor Glen Taylor on Fox Business News. Taylor discussed how Apple's AirPods Pro 2 hearing aid functionality could potentially complement Envoy Medical's product offering. He noted that Envoy Medical's fully implanted devices, which take in sound through the ear, could potentially work in concert with devices like the AirPods Pro 2.
Envoy Medical CEO Brent Lucas emphasized that their hearing implants are different from other hearing implants as they use the ear to pick up sound, referring to it as 'Nature's Microphone.' This design allows recipients to use their ears for other purposes, including external electronics, earbuds, or hearing aids. Lucas believes this flexibility will be a key differentiator and increase excitement around their fully implanted hearing implants.
Envoy Medical, Inc. (Nasdaq: COCH), un'azienda nel settore della salute uditiva focalizzata su sistemi di ascolto completamente impiantati, mette in evidenza un'intervista con l'importante investitore Glen Taylor su Fox Business News. Taylor ha discusso di come la funzionalità di auricolare Apple AirPods Pro 2 potrebbe potenzialmente completare l'offerta di prodotti di Envoy Medical. Ha osservato che i dispositivi completamente impiantati di Envoy Medical, che captano il suono attraverso l'orecchio, potrebbero lavorare in sinergia con dispositivi come gli AirPods Pro 2.
Il CEO di Envoy Medical, Brent Lucas, ha sottolineato che i loro impianti uditivi sono diversi dagli altri impianti uditivi poiché utilizzano l'orecchio per ricevere il suono, definendoli 'Il Microfono della Natura.' Questo design consente ai destinatari di utilizzare le loro orecchie per altri scopi, inclusi dispositivi elettronici esterni, auricolari o apparecchi acustici. Lucas crede che questa flessibilità sarà un differenziante chiave e aumenterà l'entusiasmo attorno ai loro impianti uditivi completamente impiantati.
Envoy Medical, Inc. (Nasdaq: COCH), una empresa de salud auditiva centrada en sistemas auditivos totalmente implantados, destaca una entrevista con el importante inversionista Glen Taylor en Fox Business News. Taylor discutió cómo la funcionalidad de Auriculares Apple AirPods Pro 2 podría complementar potencialmente la oferta de productos de Envoy Medical. Observó que los dispositivos totalmente implantados de Envoy Medical, que captan sonidos a través del oído, podrían trabajar en conjunto con dispositivos como los AirPods Pro 2.
El CEO de Envoy Medical, Brent Lucas, enfatizó que sus implantes auditivos son diferentes de otros implantes auditivos ya que utilizan el oído para captar sonidos, refiriéndose a ellos como 'El Micrófono de la Naturaleza.' Este diseño permite a los pacientes utilizar sus oídos para otros propósitos, incluidos dispositivos electrónicos externos, auriculares o audífonos. Lucas cree que esta flexibilidad será un diferenciador clave y aumentará la emoción en torno a sus implantes auditivos totalmente implantados.
Envoy Medical, Inc. (Nasdaq: COCH), 완전 임플란트 청각 시스템에 초점을 맞춘 청각 건강 회사는 Fox Business News와의 주요 투자자 Glen Taylor의 인터뷰를 강조했습니다. Taylor는 Apple의 AirPods Pro 2 보청기 기능이 Envoy Medical의 제품 제공을 어떻게 보완할 수 있을지에 대해 언급했습니다. 그는 귀를 통해 소리를 수집하는 Envoy Medical의 완전 임플란트 장치가 AirPods Pro 2와 같이 작동할 수 있다고 강조했습니다.
Envoy Medical의 CEO인 Brent Lucas는 그들의 청각 임플란트가 다른 청각 임플란트와 다르다고 강조하며, 자연의 마이크로폰이라고 불리는 귀를 통해 소리를 수집한다고 설명했습니다. 이 디자인은 수혜자가 귀를 외부 전자기기, 이어폰 또는 보청기와 같은 다른 용도로 사용할 수 있게 합니다. Lucas는 이러한 유연성이 핵심 차별점이 될 것이며 완전 임플란트 청각 임플란트에 대한 흥미를 증가시킬 것이라고 믿습니다.
Envoy Medical, Inc. (Nasdaq: COCH), une entreprise de santé auditive axée sur les systèmes auditifs entièrement implantés, met en avant une interview avec l'investisseur clé Glen Taylor sur Fox Business News. Taylor a discuté de la manière dont la fonctionnalité de l'Apple AirPods Pro 2 en tant qu'aide auditive pourrait potentiellement compléter l'offre de produits d'Envoy Medical. Il a noté que les dispositifs entièrement implantés d'Envoy Medical, qui captent le son par l'oreille, pourraient fonctionner en harmonie avec des appareils comme les AirPods Pro 2.
Le PDG d'Envoy Medical, Brent Lucas, a souligné que ses implants auditifs étaient différents des autres implants auditifs car ils utilisent l'oreille pour capter le son, les qualifiant de 'microphone de la nature.' Ce design permet aux bénéficiaires d'utiliser leurs oreilles pour d'autres fonctions, y compris des appareils électroniques externes, des écouteurs ou des aides auditives. Lucas estime que cette flexibilité sera un élément de différenciation clé et augmentera l'enthousiasme autour de leurs implants auditifs entièrement implantés.
Envoy Medical, Inc. (Nasdaq: COCH), ein Unternehmen für Hörgesundheit, das sich auf vollständig implantierte Hörsysteme konzentriert, hebt ein Interview mit dem wichtigen Investor Glen Taylor in den Fox Business News hervor. Taylor sprach darüber, wie die Funktionalität der Apple AirPods Pro 2 Hörgerät-Funktion potenziell das Produktangebot von Envoy Medical ergänzen könnte. Er bemerkte, dass die vollständig implantierten Geräte von Envoy Medical, die Schall über das Ohr aufnehmen, möglicherweise in Zusammenarbeit mit Geräten wie den AirPods Pro 2 arbeiten könnten.
Der CEO von Envoy Medical, Brent Lucas, betonte, dass ihre Hörimplantate anders sind als andere Hörimplantate, da sie das Ohr zur Schallaufnahme nutzen und es als 'Mikrofon der Natur' bezeichnen. Dieses Design ermöglicht es den Nutzern, ihre Ohren für andere Zwecke zu verwenden, einschließlich externer Elektronik, Kopfhörer oder Hörgeräte. Lucas glaubt, dass diese Flexibilität ein wichtiger Unterschied sein wird und die Begeisterung für ihre vollständig implantierten Hörgeräte erhöhen wird.
- Potential synergy between Envoy Medical's implants and Apple's AirPods Pro 2
- Unique design of Envoy Medical's implants allows for use with other hearing devices
- Investor Glen Taylor views Apple's entry into hearing technology as potentially additive
- None.
During “The Claman Countdown,” the billionaire investor and entrepreneur noted how hearing aid modes in next-gen wireless earbuds can work with Envoy Medical’s fully implanted hearing devices
WHITE BEAR LAKE, Minnesota, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: “COCH”), a hearing health company focused on fully implanted hearing systems, today highlights an interview with key investor Glen Taylor on Fox Business News “The Claman Countdown” in which he commented on the news that Apple’s new AirPods Pro 2 can be used as hearing aids.
In the interview, Mr. Taylor was asked whether he was worried about Apple entering the hearing technology market, and he discussed how he believed it could be additive to Envoy Medical’s product offering. Mr. Taylor noted that due to Envoy Medical’s fully implanted devices taking in sound through the ear, devices like the AirPods Pro 2 could potentially work in concert with Envoy Medical’s fully implanted devices. Envoy Medical’s hearing devices are not hearing aids, but rather fully implanted hearing devices for a particular subset of hearing loss.
Envoy Medical CEO, Brent Lucas stated, “Our hearing implants are different from other hearing implants in that ours use the ear to pick up sound. We sometimes refer to it as ‘Nature’s Microphone.’ The device design of our hearing implants allows recipients to use the ears for other things, such as external electronics, earbuds, or even hearing aids. Once the market appreciates why we believe this is going to be a differentiator, we believe it will increase excitement around our fully implanted hearing implants and the flexibility they can provide to certain patients.”
About the Esteem® Fully Implanted Active Middle Ear Implant (FI-AMEI)
The Esteem fully implanted active middle ear implant (FI-AMEI) is the only FDA-approved, fully implanted* hearing device for adults diagnosed with moderate to severe sensorineural hearing loss allowing for 24/7 hearing capability using the ear’s natural anatomy. The Esteem FI-AMEI hearing implant is invisible and requires no externally worn components and nothing is placed in the ear canal for it to function. Unlike hearing aids, you never put it on or take it off. You can’t lose it. You don’t clean it. The Esteem FI-AMEI hearing implant offers true 24/7 hearing.
*Once activated, the external Esteem FI-AMEI Personal Programmer is not required for daily use.
Important safety information for the Esteem FI-AMEI can be found at: https://www.envoymedical.com/safety-information.
About the Fully Implanted Acclaim® Cochlear Implant
We believe the fully implanted Acclaim Cochlear Implant (“Acclaim CI”) will be a first-of-its-kind fully implanted cochlear implant. Envoy Medical’s fully implanted technology includes a sensor designed to leverage the natural anatomy of the ear instead of a microphone to capture sound.
The Acclaim CI is designed to address severe to profound sensorineural hearing loss that is not adequately addressed by hearing aids. The Acclaim CI is expected to be indicated for adults who have been deemed adequate candidates by a qualified physician.
The Acclaim Cochlear Implant received the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) in 2019. We believe the Acclaim CI was the first hearing-focused device to receive Breakthrough Device Designation.
CAUTION The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use.
Additional Information and Where to Find It
Copies of the documents filed by Envoy Medical with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov.
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-Looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. Such statements may include, but are not limited to, statements regarding the expectations of Envoy Medical concerning the outlook for its business, productivity, plans and goals for future operational improvements and capital investments; the effect of the ability to use electronic devices with the Acclaim CI; the potential for passage of legislation related to reimbursement for active middle ear hearing devices; the impact that such proposed legislation might have on the hearing health market, reimbursement for the Esteem FI-AMEI device, and the Envoy Medical business, and future market conditions or economic performance, as well as any information concerning possible or assumed future operations of Envoy Medical. The forward-looking statements contained in this press release reflect Envoy Medical’s current views about future events and are subject to numerous known and unknown risks, uncertainties, assumptions and changes in circumstances that may cause its actual results to differ significantly from those expressed in any forward-looking statement. Envoy Medical does not guarantee that the events described will happen as described (or that they will happen at all). These forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to changes in the market price of shares of Envoy Medical’s Class A Common Stock; changes in or removal of Envoy Medical’s shares inclusion in any index; Envoy Medical’s success in retaining or recruiting, or changes required in, its officers, key employees or directors; unpredictability in the medical device industry, the regulatory process to approve medical devices, and the clinical development process of Envoy Medical products; competition in the medical device industry, and the failure to introduce new products and services in a timely manner or at competitive prices to compete successfully against competitors; disruptions in relationships with Envoy Medical’s suppliers, or disruptions in Envoy Medical’s own production capabilities for some of the key components and materials of its products; changes in the need for capital and the availability of financing and capital to fund these needs; changes in interest rates or rates of inflation; legal, regulatory and other proceedings could be costly and time-consuming to defend; changes in applicable laws or regulations, or the application thereof on Envoy Medical; a loss of any of Envoy Medical’s key intellectual property rights or failure to adequately protect intellectual property rights; the effects of catastrophic events, including war, terrorism and other international conflicts; and other risks and uncertainties set forth in the section entitled “Risk Factors” and “Cautionary Note Regarding Forward Looking Statements” in the Annual Report on Form 10-K filed by Envoy Medical on April 1, 2024, and in other reports Envoy Medical files, with the SEC. If any of these risks materialize or Envoy Medical’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. While forward-looking statements reflect Envoy Medical’s good faith beliefs, they are not guarantees of future performance. Envoy Medical disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based only on information currently available to Envoy Medical.
###
Investor Contact:
CORE IR
516-222-2560
investorrelations@envoymedical.com
FAQ
How might Apple's AirPods Pro 2 hearing aid functionality impact Envoy Medical (COCH)?
What is unique about Envoy Medical's (COCH) hearing implants?
How does Envoy Medical (COCH) view the potential impact of Apple's entry into hearing technology?
